Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: Impact on ovarian stimulation. A pilot study

Fertility and Sterility

Volumn 95, Issue 5, 2011, Pages

  Blockeel, Christophe ^a,c   Riva, Arianna ^a   De Vos, Michel ^a   Haentjens, Patrick ^b   Devroey, Paul ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b Laboratory of Experimental Surgery   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

GnRH antagonist; ICSI; IVF; ovarian stimulation

Indexed keywords

CETRORELIX; ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 79952921044     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.01.028     Document Type: Article

References (29)

1. European and Middle East Orgalutran Study Group Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation Hum Reprod 16 2001 644 651
2. H.G. Al-Inany, A.M. Abou-Setta, and M. Aboulghar Gonadotrophin-releasing hormone antagonists for assisted conception Cochrane Database Syst Rev 3 2006 CD001750
3. P. Devroey, M. Aboulghar, J. Garcia-Velasco, G. Griesinger, P. Humaidan, and E. Kolibianakis Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment Hum Reprod 24 2009 764 774
4. E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, and G. Griesinger Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis Hum Reprod Update 12 2006 651 671 (Pubitemid 44605507)
5. R. Fanchin, L. Salomon, A. Castelo-Branco, F. Olivennes, N. Frydman, and R. Frydman Luteal estradiol pretreatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists Hum Reprod 18 2003 2698 2703 (Pubitemid 37536643)
6. A. Guivarc'h-Levêque, P. Arvis, J.L. Bouchet, P.L. Broux, L. Moy, and G. Priou Efficiency of antagonist IVF cycle programming by estrogens Gynecol Obstet Fertil 38 2010 18 22
7. G. Griesinger, C.A. Venetis, T. Marx, K. Diedrich, B.C. Tarlatzis, and E.M. Kolibianakis Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis Fertil Steril 90 2008 1055 1063
8. G. Griesinger, E.M. Kolibianakis, C. Venetis, K. Diedrich, and B. Tarlatzis Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis Fertil Steril 94 2010 2382 2384
9. M.J. Levy, K. Gordon, and P.C. Ijzerman-Boon Reducing the incidence of weekend oocyte retrievals in GnRH antagonist protocols by selective initiation of COS on cycle day 1 through 4 Fertil Steril 92 2009 S167 S168
10. K.P. Tremellen, and M. Lane Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes Hum Reprod 25 2010 1219 1224
11. E.M. Kolibianakis, K. Zikopoulos, J. Smitz, M. Camus, H. Tournaye, and A.C. Van Steirteghem Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists Hum Reprod 19 2004 1525 1529 (Pubitemid 38997175)
12. C. Blockeel, M. Baumgarten, M. De Vos, G. Verheyen, and P. Devroey Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: a prospective cohort study Curr Pharm Biotech 2010 Dec 6. [Epub ahead of print.]
13. E. Papanikolaou, E. D'haeseleer, G. Verheyen, H. Van de Velde, M. Camus, and A. Van Steirteghem Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture: a randomized prospective study Hum Reprod 20 2005 3198 3203 (Pubitemid 41662678)
14. E. Papanikolaou, C. Bourgain, E. Kolibianakis, H. Tournaye, and P. Devroey Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes Hum Reprod 20 2005 1541 1547 (Pubitemid 40852245)
15. L. Van Landuyt, A. Devos, H. Joris, G. Verheyen, P. Devroey, and A. Van Steirteghem Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization process Fertil Steril 83 2005 1397 1403 (Pubitemid 40615811)
16. D.K. Gardner, and W.B. Schoolcraft Culture and transfer of human blastocysts Hum Reprod 13 1999 3434 3440
17. D.G. Altman Practical statistics for medical research 1991 Chapman and Hall London
18. J.S. Younis, S. Soltsman, I. Izhaki, O. Radin, S. Bar-Ami, and M. Ben-Ami Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization-embryo transfer cycles Fertil Steril 94 2010 1350 1355
19. J.A. Huirne, R. Homburg, and C.B. Lambalk Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod 22 2007 2805 2813 (Pubitemid 351696806)
20. C. Albano, R.E. Felberbaum, J. Smitz, H. Riethmüller-Winzen, J. Engel, and K. Diedrich Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group Hum Reprod 15 2000 526 531 (Pubitemid 30142356)
21. G. Borm, and B. Mannaerts Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group Hum Reprod 15 2000 1490 1498
22. D. De Ziegler Hormonal control of endometrial receptivity Hum Reprod 10 1995 4 7
23. A.M. Van Heusden, and B.C. Fauser Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives Contraception 59 1999 237 243 (Pubitemid 29361479)
24. E.M. Kolibianakis, C. Albano, J. Kahn, M. Camus, H. Tournaye, and A.C. Van Steirteghem Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy Fertil Steril 79 2003 873 880 (Pubitemid 36385006)
25. E.M. Kolibianakis, K. Zikopoulos, J. Smitz, M. Camus, H. Tournaye, and A.C. Van Steirteghem Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization Fertil Steril 82 2004 223 226 (Pubitemid 38968805)
26. J.E. Hall, N. Bhatta, J.M. Adams, J.E. Rivier, W.W. Vale, and W.F. Crowley Jr. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human J Clin Endocrinol Metab 72 1991 993 1000 (Pubitemid 21921797)
27. J.J. Oberyé, B.M. Mannaerts, J.A. Huisman, and C.J. Timmer Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers Fertil Steril 72 1999 1006 1012
28. D. Kyrou, B. Popovic-Todorovic, H.M. Fatemi, C. Bourgain, P. Haentjens, and L. Van Landuyt Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? Hum Reprod 24 2009 2902 2909
29. E. Bosch, E. Labarta, J. Crespo, C. Simón, J. Remohí, and J. Jenkins Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles Hum Reprod 25 2010 2092 2100